Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034Martin J. van den Bent, Thierry Gorlia, Mario Campone et al.|Journal of Clinical Oncology|2009Cited by 573
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Anna Maria Cremonini, Alicia Tosoni et al.|World Neurosurgery|2018Cited by 59
Caregiver professional employment and its impact on glioblastoma patient survival: Results from two prospective studies.Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni et al.|Journal of Clinical Oncology|2026Cited by 0
Financial toxicity, Socioeconomic Status, and clinical outcome in Glioblastoma: the ISES-2 Prospective Multicenter Italian StudyAlicia Tosoni, Enrico Franceschi, Laura Arenare et al.|SSRN Electronic Journal|2026Cited by 0